On behalf of all of the Practice Business team, we’d like to wish you a very merry Christmas and the happiest of new years!
As we head into the festive season, we will be pausing our news and features service and will return with a bang in January! Our offices are closed between 12pm on the 23rd of December and 9am on the 3rd of January 2023.
This past year has been another challenging one for all in the primary care sector and we look forward to standing by your side during the changes and challenges still to come and supporting you through our online stories and features in the new year.
We’re optimistic about 2023 and look forward to the opportunities that will present themselves! While we understand that there are still challenges ahead, we are inspired by the level of resilience, dedication and innovation that those working in the primary care sector continue to bring to the table.
So all that’s left to say in the meantime is, merry Christmas from all of us at Practice Business headquarters! However you celebrate, we hope you have fun. Enjoy the festivities and we’ll see you in the new year!
Adverse events should be reported. Reporting forms and information can be found at yellowcard.mhra.gov.uk. Adverse events relating to CSL Seqirus products should also be reported to Seqirus UK Limited on 01748 828816.
1. Seqirus Data on File, August 2023. SREF–17994. 2. Adjuvanted Trivalent Influenza Vaccine (surface antigen, inactivated)▼ Summary of Product Characteristics. 3. Cell-based Trivalent Influenza Vaccine (surface antigen, inactivated)▼ Summary of Product Characteristics.
Be the first to comment